BridgeBio Pharma (BBIO) EPS (Basic) (2018 - 2026)
BridgeBio Pharma (BBIO) reported EPS (Basic) of -$0.84 for Q1 2026, up 4.35% on a YoY basis from -$0.81 in Q1 2025, and up 16.37% sequentially from -$1.01 in Q4 2025.
BridgeBio Pharma (BBIO) EPS (Basic) (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of EPS (Basic) data on file, last reported at -$0.84 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 4.35% year-over-year to -$0.84; the trailing twelve-month figure through Mar 2026 stood at -$3.7 (down 5.45% YoY), and the FY2025 full-year result was -$3.78, down 31.46% from the prior year.
- EPS (Basic) climbed to -$0.84 in Q1 2026, from -$1.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.07 in Q2 2022 to a low of -$1.42 in Q4 2024.
- A 5-year average of -$0.87 and a median of -$0.93 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 89.77% in 2022 and slumped 1363.84% in 2023, its largest moves.
- Tracing BBIO's EPS (Basic) over 5 years: stood at -$0.93 in 2022, then declined by 10.71% to -$1.03 in 2023, then tumbled by 37.9% to -$1.42 in 2024, then advanced by 29.31% to -$1.01 in 2025, then increased by 16.37% to -$0.84 in 2026.
- Business Quant data shows BBIO's EPS (Basic) at -$0.84 in Q1 2026, -$1.01 in Q4 2025, and -$0.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -0.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -1.01 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | -0.95 |
| Mar 31, 2025 | -0.88 |
| Dec 31, 2024 | -1.42 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -1.03 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.92 |
| Dec 31, 2022 | -0.93 |
| Sep 30, 2022 | -0.93 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -1.35 |
| Dec 31, 2021 | -1.02 |
| Sep 30, 2021 | -1.06 |
| Jun 30, 2021 | -0.66 |